Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Transcutaneous Vagus Nerve Stimulation for the Treatment of Lupus
Phase 2
Terminated
- Conditions
- Systemic Lupus Erythematosus
- First Posted Date
- 2016-09-28
- Last Posted Date
- 2020-03-03
- Lead Sponsor
- Aikaterini Thanou
- Target Recruit Count
- 7
- Registration Number
- NCT02917265
- Locations
- 🇺🇸
Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States
News
No news found